{"id":365130,"date":"2025-09-01T04:52:58","date_gmt":"2025-09-01T04:52:58","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-avanos-medical\/"},"modified":"2025-09-01T04:52:58","modified_gmt":"2025-09-01T04:52:58","slug":"how-to-buy-avanos-medical","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/","title":{"rendered":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-365130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Avanos Medical (AVNS) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizleri, 2025-2030 tahminleri ve sa\u011fl\u0131k sekt\u00f6r\u00fc f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Avanos Medical (AVNS) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizleri, 2025-2030 tahminleri ve sa\u011fl\u0131k sekt\u00f6r\u00fc f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini \u00f6\u011frenin."},"intro":"G\u00fcnl\u00fck hayat\u0131 etkileyen t\u0131bbi yeniliklere yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Avanos Medical, hastalar\u0131n daha h\u0131zl\u0131 iyile\u015fmesine yard\u0131mc\u0131 olan a\u011fr\u0131 y\u00f6netimi ve beslenme \u00e7\u00f6z\u00fcmlerinde uzmanla\u015fm\u0131\u015f, sa\u011fl\u0131k teknolojisinin \u00f6nc\u00fcs\u00fcn\u00fc temsil ediyor. Ya\u015flanan n\u00fcfusun sa\u011fl\u0131k hizmetlerine olan talebi art\u0131rmas\u0131yla, bu \u015firket t\u0131bbi gereklilik ile teknolojik ilerlemenin kesi\u015fim noktas\u0131nda yer al\u0131yor ve ileri g\u00f6r\u00fc\u015fl\u00fc yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir f\u0131rsat sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"G\u00fcnl\u00fck hayat\u0131 etkileyen t\u0131bbi yeniliklere yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Avanos Medical, hastalar\u0131n daha h\u0131zl\u0131 iyile\u015fmesine yard\u0131mc\u0131 olan a\u011fr\u0131 y\u00f6netimi ve beslenme \u00e7\u00f6z\u00fcmlerinde uzmanla\u015fm\u0131\u015f, sa\u011fl\u0131k teknolojisinin \u00f6nc\u00fcs\u00fcn\u00fc temsil ediyor. Ya\u015flanan n\u00fcfusun sa\u011fl\u0131k hizmetlerine olan talebi art\u0131rmas\u0131yla, bu \u015firket t\u0131bbi gereklilik ile teknolojik ilerlemenin kesi\u015fim noktas\u0131nda yer al\u0131yor ve ileri g\u00f6r\u00fc\u015fl\u00fc yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir f\u0131rsat sunuyor."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Stratejisi<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla Avanos Medical (AVNS) hisseleri <strong>11,94 $<\/strong> seviyesinde i\u015flem g\u00f6rmekte olup, bir\u00e7ok analistin uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir giri\u015f noktas\u0131 olarak de\u011ferlendirdi\u011fi bir fiyat sunmaktad\u0131r. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131 ancak \u015fu anda sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bir y\u00fckseli\u015f potansiyeli sunabilecek seviyelerde bulunmaktad\u0131r.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>29 Ekim 2025<\/strong> tarihini i\u015faretleyin\u2014Avanos bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00f6nemli fiyat hareketlerine neden olmu\u015ftur. \u00d6nceki 2. \u00e7eyrek raporu 5 A\u011fustos 2025'te beklentileri a\u015farak 175 milyon $ gelir bildirmi\u015ftir (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/AVNS\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>), ancak hisse ba\u015f\u0131 kazan\u00e7 (EPS) tahminlerin biraz alt\u0131nda kalm\u0131\u015ft\u0131r.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <p>Son \u00e7eyrek performanslar\u0131na bak\u0131ld\u0131\u011f\u0131nda dikkat edilmesi gereken bir desen ortaya \u00e7\u0131kmaktad\u0131r:<\/p> <table> <thead> <tr> <th>\u00c7eyrek<\/th> <th>EPS Tahmini<\/th> <th>Ger\u00e7ek EPS<\/th> <th>Gelir Tahmini<\/th> <th>Ger\u00e7ek Gelir<\/th> <th>Fiyat Etkisi<\/th> <\/tr> <\/thead> <tbody> <tr> <td>2025 2. \u00c7eyrek<\/td> <td>0,18 $<\/td> <td>0,17 $<\/td> <td>165,5M $<\/td> <td>175,0M $<\/td> <td>Kar\u0131\u015f\u0131k tepki<\/td> <\/tr> <tr> <td>2025 1. \u00c7eyrek<\/td> <td>0,18 $<\/td> <td>0,26 $<\/td> <td>-<\/td> <td>-<\/td> <td>%44 s\u00fcrpriz art\u0131\u015f<\/td> <\/tr> <tr> <td>2024 4. \u00c7eyrek<\/td> <td>0,40 $<\/td> <td>0,43 $<\/td> <td>-<\/td> <td>-<\/td> <td>%7,5 \u00fczeri<\/td> <\/tr> <\/tbody> <\/table> <p>Desen, gelir performans\u0131n\u0131n g\u00fc\u00e7l\u00fc oldu\u011funu ancak kazan\u00e7 tutarl\u0131l\u0131\u011f\u0131n\u0131n zorluk ya\u015fad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir. Ancak \u015firketin gelir beklentilerini a\u015fma yetene\u011fi, temel i\u015f g\u00fcc\u00fcn\u00fcn sa\u011flam oldu\u011funu i\u015faret etmektedir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2> <p>Avanos Medical hisseleri son alt\u0131 ayda dalgal\u0131 seyir izlemi\u015f, hem zorluklar hem de f\u0131rsatlar sunmu\u015ftur:<\/p> <ul> <li><strong>Mart 2025<\/strong>: \u015eirket d\u00f6n\u00fc\u015f\u00fcm stratejisini uygulamaya ba\u015flarken hisse yakla\u015f\u0131k 12,60 $ seviyelerinde i\u015flem g\u00f6rd\u00fc<\/li> <li><strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek sonu\u00e7lar\u0131n\u0131n beklentilerin \u00fczerinde gelmesiyle fiyatlar yakla\u015f\u0131k 12,64 $ seviyesine ula\u015ft\u0131<\/li> <li><strong>Haziran 2025<\/strong>: Piyasa duyarl\u0131l\u0131\u011f\u0131n\u0131n de\u011fi\u015fmesiyle 12,14 $ seviyesine \u0131l\u0131ml\u0131 bir d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131<\/li> <li><strong>A\u011fustos 2025<\/strong>: Mevcut seviyeler 11,94 $ civar\u0131nda konsolidasyon evresini temsil ediyor<\/li> <\/ul> <p>Genel trend, Mart zirvesinden itibaren <strong>%5,5 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6stermektedir ancak bu, sa\u011fl\u0131k sekt\u00f6r\u00fcndeki genel zorluklar ve \u015firketin stratejik yeniden konumland\u0131rmas\u0131 ba\u011flam\u0131nda de\u011ferlendirilmelidir.<\/p> <p>Bu performans\u0131n arkas\u0131ndaki temel etkenler \u015funlard\u0131r:<\/p> <ul> <li>Maliyet y\u00f6netimi giri\u015fimlerinin ba\u015far\u0131l\u0131 uygulanmas\u0131<\/li> <li>Organizasyonel yeniden yap\u0131land\u0131rma \u00e7abalar\u0131<\/li> <li>Birle\u015fik Krall\u0131k gibi \u00f6nemli pazarlarda do\u011frudan operasyonlar\u0131n geni\u015fletilmesi<\/li> <li>Daha y\u00fcksek marjl\u0131 \u00fcr\u00fcnlere y\u00f6nelik portf\u00f6y d\u00f6n\u00fc\u015f\u00fcm\u00fcn\u00fcn devam etmesi<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak yat\u0131r\u0131mc\u0131lar\u0131n bekleyebilece\u011fi \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 12,50-13,50 $ aral\u0131\u011f\u0131 \u2192 Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>AL<\/strong> tavsiyesi<br> \u015eirketin 2025 i\u00e7in 665-685 milyon $ gelir rehberli\u011fi istikrar\u0131 i\u015faret ederken, maliyet kontrol \u00f6nlemleri marjlar\u0131 iyile\u015ftirmelidir<\/li> <li><strong>2026 Projeksiyonu<\/strong>: 14,00-16,00 $<br> <a href=\"https:\/\/www.moomoo.com\/stock\/AVNS-US\/forecast\/\">Moomoo<\/a> analistleri ortalama 12 ayl\u0131k hedefleri yakla\u015f\u0131k 14,00 $ olarak \u00f6ng\u00f6rmekte, daha iyimser tahminler ise 17,34 $ seviyesine kadar \u00e7\u0131kmaktad\u0131r<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 18,00-22,00 $<br> D\u00f6n\u00fc\u015f\u00fcm stratejisinin ve pazar geni\u015flemesinin ba\u015far\u0131l\u0131 uygulanmas\u0131 varsay\u0131m\u0131yla<\/li> <li><strong>2030 Vizyonu<\/strong>: 25,00 $+ potansiyel<br> Sa\u011fl\u0131k harcamalar\u0131ndaki uzun vadeli demografik trendler s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmeyi desteklemektedir<\/li> <\/ul> <p>Yat\u0131r\u0131m tezi, Avanos'un d\u00f6n\u00fc\u015f\u00fcm stratejisini ba\u015far\u0131yla uygulamas\u0131 ve ya\u015flanan n\u00fcfus trendleri ile artan sa\u011fl\u0131k harcamalar\u0131ndan faydalanmas\u0131na dayanmaktad\u0131r.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve Avanos Medical birka\u00e7 \u00f6nemli husus sunmaktad\u0131r:<\/p> <ul> <li><strong>Reg\u00fclasyon Riskleri<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fc yo\u011fun \u015fekilde d\u00fczenlenmi\u015ftir, de\u011fi\u015fiklikler \u00fcr\u00fcn onaylar\u0131n\u0131 ve geri \u00f6deme oranlar\u0131n\u0131 etkileyebilir<\/li> <li><strong>Mali Zorluklar<\/strong>: \u015eirket, 2025 2. \u00e7eyrekte de\u011fer d\u00fc\u015f\u00fckl\u00fc\u011f\u00fc giderleri nedeniyle 76,8 milyon $ net zarar bildirmi\u015ftir (<a href=\"https:\/\/www.ainvest.com\/news\/avanos-medical-2025-q2-earnings-sharp-net-loss-revenue-growth-2508\/\">AInvest Raporu<\/a>)<\/li> <li><strong>Rekabet Bask\u0131s\u0131<\/strong>: T\u0131bbi cihaz end\u00fcstrisinde rekabet s\u00fcrekli artmaktad\u0131r<\/li> <li><strong>Uygulama Riski<\/strong>: D\u00f6n\u00fc\u015f\u00fcm stratejileri her zaman beklenen sonu\u00e7lar\u0131 vermeyebilir<\/li> <\/ul> <p>Ancak bu riskler, \u015firketin g\u00fc\u00e7l\u00fc piyasa konumlar\u0131 ve \u00f6zel t\u0131bbi \u00e7\u00f6z\u00fcmlerine artan talep ile dengelenmelidir.<\/p> <h2>\ud83d\udfe2 Olumlu \u0130\u015faretler: Yat\u0131r\u0131mc\u0131lar\u0131n \u0130yimser Olmas\u0131n\u0131n Nedenleri<\/h2> <p>Avanos Medical'in toparlanmaya haz\u0131r olabilece\u011fini g\u00f6steren birka\u00e7 fakt\u00f6r vard\u0131r:<\/p> <ul> <li><strong>Birle\u015fik Krall\u0131k Geni\u015fleme Ba\u015far\u0131s\u0131<\/strong>: Temmuz 2025'te MIC-KEY \u00fcr\u00fcnleri i\u00e7in do\u011frudan operasyonlara ge\u00e7i\u015f (<a href=\"https:\/\/avanos.com\/news\/avanos-expands-direct-operations-for-mic-key-enteral-feeding-products-in-the-uk-starting-july-2025\/\">\u015eirket Duyurusu<\/a>) marjlar\u0131 ve m\u00fc\u015fteri ili\u015fkilerini iyile\u015ftirmelidir<\/li> <li><strong>Gelir \u0130stikrar\u0131<\/strong>: 2025 2. \u00e7eyrek sat\u0131\u015flar\u0131 y\u0131ll\u0131k %1,9 art\u0131\u015fla 175 milyon $ olmu\u015ftur<\/li> <li><strong>Pazar Liderli\u011fi<\/strong>: Enteral beslenme ve opioid d\u0131\u015f\u0131 a\u011fr\u0131 y\u00f6netiminde g\u00fc\u00e7l\u00fc konumlar<\/li> <li><strong>D\u00f6n\u00fc\u015f\u00fcm \u0130lerlemesi<\/strong>: Maliyet y\u00f6netimi ve organizasyonel yeniden yap\u0131land\u0131rma erken sonu\u00e7lar g\u00f6stermektedir<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2> <p>Mevcut analizlere dayanarak, yeni yat\u0131r\u0131mc\u0131lar i\u00e7in mant\u0131kl\u0131 olan \u015funlard\u0131r:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3'\u00fcnden fazlas\u0131n\u0131 temsil etmeyen bir pozisyonla ba\u015flay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Pozisyonunuzu tek seferde b\u00fcy\u00fck al\u0131m yapmak yerine kademeli olarak olu\u015fturmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Daha iyi giri\u015f noktalar\u0131 i\u00e7in 11,50 $ alt\u0131ndaki f\u0131rsatlar\u0131 izleyin<\/li> <li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu yat\u0131r\u0131m sab\u0131r gerektirir\u2014aylar de\u011fil, y\u0131llar baz\u0131nda d\u00fc\u015f\u00fcn\u00fcn<\/li> <\/ol> <p>Mizahi deneyimli t\u00fcccar \u00f6\u011f\u00fcd\u00fc: \"AVNS ticareti t\u0131bbi iyile\u015fme gibidir\u2014bazen uzun vadeli kazan\u00e7 i\u00e7in k\u0131sa vadeli ac\u0131ya katlanman\u0131z gerekir. Ama do\u011fru e\u011fitim olmadan ameliyat yapmaya kalkmay\u0131n!\"<\/p> <h2>\u2705 Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir Ticaret Platformu Se\u00e7in<\/td> <td>NYSE eri\u015fimi ve makul komisyon oranlar\u0131 sundu\u011fundan emin olun<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td> <td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>3<\/td> <td>\"AVNS\" Aramas\u0131 Yap\u0131n<\/td> <td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td> <td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>\u0130nceleyin ve Onaylay\u0131n<\/td> <td>Emir detaylar\u0131n\u0131 son kez kontrol edin<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Giri\u015f Engeli<\/strong>: 5 $ minimum depozito ile stratejileri \u00f6nemli finansal taahh\u00fct olmadan test edebilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek bir belge ile 1 dakikal\u0131k KYC s\u00fcreci sayesinde hemen i\u015flem yapmaya ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla y\u00f6ntem esneklik sa\u011flar<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve d\u00fc\u015f\u00fck giri\u015f gereksinimleri, Avanos Medical gibi \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Avanos Medical: Sa\u011fl\u0131kta Yenilik Lideri<\/h2> <p>Avanos Medical, k\u00fcresel t\u0131bbi teknoloji alan\u0131nda \u00f6nemli bir oyuncu olarak, iki kritik alanda uzmanla\u015fm\u0131\u015ft\u0131r: <strong>Kronik Bak\u0131m<\/strong> ve <strong>A\u011fr\u0131 Y\u00f6netimi<\/strong>. \u015eirket, hastalar\u0131n hastaneden ev bak\u0131m\u0131na ge\u00e7i\u015fini kolayla\u015ft\u0131ran ve opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltan narkotik olmayan a\u011fr\u0131 y\u00f6netimi teknolojileri geli\u015ftirmektedir.<\/p> <p>\u015eirketin \u00fcr\u00fcn portf\u00f6y\u00fc \u015funlar\u0131 i\u00e7erir:<\/p> <ul> <li>Hayati beslenme deste\u011fi sa\u011flayan enteral beslenme sistemleri<\/li> <li>A\u011fr\u0131 y\u00f6netimi i\u00e7in radyo frekans ablasyon ekipmanlar\u0131<\/li> <li>Hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftiren cerrahi iyile\u015fme \u00e7\u00f6z\u00fcmleri<\/li> <li>K\u0131r\u0131lgan yenido\u011fanlar i\u00e7in yenido\u011fan yo\u011fun bak\u0131m \u00fcr\u00fcnleri<\/li> <\/ul> <p>ABD, Avrupa ve Asya'da faaliyet g\u00f6steren Avanos, k\u00fcresel bir ayak izine sahip olup, kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lara y\u00f6nelik y\u00fcksek marjl\u0131 \u00f6zel \u00fcr\u00fcnlere odaklanmaktad\u0131r.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Avanos, 29 y\u0131ll\u0131k da\u011f\u0131t\u0131m ortakl\u0131\u011f\u0131n\u0131 sonland\u0131rarak Birle\u015fik Krall\u0131k operasyonlar\u0131n\u0131 do\u011frudan kontrol alt\u0131na alm\u0131\u015ft\u0131r\u2014bu cesur hamle, \u00fcr\u00fcnlerine olan g\u00fcveni ve m\u00fc\u015fteri ili\u015fkilerine ba\u011fl\u0131l\u0131\u011f\u0131 g\u00f6stermektedir. Bu stratejik de\u011fi\u015fim 25 Temmuz 2025'te ba\u015flam\u0131\u015f ve \u015firketin agresif pazar geni\u015fleme yakla\u015f\u0131m\u0131n\u0131 temsil etmektedir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Stratejisi<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla Avanos Medical (AVNS) hisseleri <strong>11,94 $<\/strong> seviyesinde i\u015flem g\u00f6rmekte olup, bir\u00e7ok analistin uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir giri\u015f noktas\u0131 olarak de\u011ferlendirdi\u011fi bir fiyat sunmaktad\u0131r. Hisse senedi 2025 boyunca \u00f6nemli dalgalanmalar ya\u015fad\u0131 ancak \u015fu anda sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bir y\u00fckseli\u015f potansiyeli sunabilecek seviyelerde bulunmaktad\u0131r.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>29 Ekim 2025<\/strong> tarihini i\u015faretleyin\u2014Avanos bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00f6nemli fiyat hareketlerine neden olmu\u015ftur. \u00d6nceki 2. \u00e7eyrek raporu 5 A\u011fustos 2025&#8217;te beklentileri a\u015farak 175 milyon $ gelir bildirmi\u015ftir (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/AVNS\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>), ancak hisse ba\u015f\u0131 kazan\u00e7 (EPS) tahminlerin biraz alt\u0131nda kalm\u0131\u015ft\u0131r.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>Son \u00e7eyrek performanslar\u0131na bak\u0131ld\u0131\u011f\u0131nda dikkat edilmesi gereken bir desen ortaya \u00e7\u0131kmaktad\u0131r:<\/p>\n<table>\n<thead>\n<tr>\n<th>\u00c7eyrek<\/th>\n<th>EPS Tahmini<\/th>\n<th>Ger\u00e7ek EPS<\/th>\n<th>Gelir Tahmini<\/th>\n<th>Ger\u00e7ek Gelir<\/th>\n<th>Fiyat Etkisi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2025 2. \u00c7eyrek<\/td>\n<td>0,18 $<\/td>\n<td>0,17 $<\/td>\n<td>165,5M $<\/td>\n<td>175,0M $<\/td>\n<td>Kar\u0131\u015f\u0131k tepki<\/td>\n<\/tr>\n<tr>\n<td>2025 1. \u00c7eyrek<\/td>\n<td>0,18 $<\/td>\n<td>0,26 $<\/td>\n<td>&#8211;<\/td>\n<td>&#8211;<\/td>\n<td>%44 s\u00fcrpriz art\u0131\u015f<\/td>\n<\/tr>\n<tr>\n<td>2024 4. \u00c7eyrek<\/td>\n<td>0,40 $<\/td>\n<td>0,43 $<\/td>\n<td>&#8211;<\/td>\n<td>&#8211;<\/td>\n<td>%7,5 \u00fczeri<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Desen, gelir performans\u0131n\u0131n g\u00fc\u00e7l\u00fc oldu\u011funu ancak kazan\u00e7 tutarl\u0131l\u0131\u011f\u0131n\u0131n zorluk ya\u015fad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir. Ancak \u015firketin gelir beklentilerini a\u015fma yetene\u011fi, temel i\u015f g\u00fcc\u00fcn\u00fcn sa\u011flam oldu\u011funu i\u015faret etmektedir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2>\n<p>Avanos Medical hisseleri son alt\u0131 ayda dalgal\u0131 seyir izlemi\u015f, hem zorluklar hem de f\u0131rsatlar sunmu\u015ftur:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: \u015eirket d\u00f6n\u00fc\u015f\u00fcm stratejisini uygulamaya ba\u015flarken hisse yakla\u015f\u0131k 12,60 $ seviyelerinde i\u015flem g\u00f6rd\u00fc<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek sonu\u00e7lar\u0131n\u0131n beklentilerin \u00fczerinde gelmesiyle fiyatlar yakla\u015f\u0131k 12,64 $ seviyesine ula\u015ft\u0131<\/li>\n<li><strong>Haziran 2025<\/strong>: Piyasa duyarl\u0131l\u0131\u011f\u0131n\u0131n de\u011fi\u015fmesiyle 12,14 $ seviyesine \u0131l\u0131ml\u0131 bir d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: Mevcut seviyeler 11,94 $ civar\u0131nda konsolidasyon evresini temsil ediyor<\/li>\n<\/ul>\n<p>Genel trend, Mart zirvesinden itibaren <strong>%5,5 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6stermektedir ancak bu, sa\u011fl\u0131k sekt\u00f6r\u00fcndeki genel zorluklar ve \u015firketin stratejik yeniden konumland\u0131rmas\u0131 ba\u011flam\u0131nda de\u011ferlendirilmelidir.<\/p>\n<p>Bu performans\u0131n arkas\u0131ndaki temel etkenler \u015funlard\u0131r:<\/p>\n<ul>\n<li>Maliyet y\u00f6netimi giri\u015fimlerinin ba\u015far\u0131l\u0131 uygulanmas\u0131<\/li>\n<li>Organizasyonel yeniden yap\u0131land\u0131rma \u00e7abalar\u0131<\/li>\n<li>Birle\u015fik Krall\u0131k gibi \u00f6nemli pazarlarda do\u011frudan operasyonlar\u0131n geni\u015fletilmesi<\/li>\n<li>Daha y\u00fcksek marjl\u0131 \u00fcr\u00fcnlere y\u00f6nelik portf\u00f6y d\u00f6n\u00fc\u015f\u00fcm\u00fcn\u00fcn devam etmesi<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak yat\u0131r\u0131mc\u0131lar\u0131n bekleyebilece\u011fi \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 12,50-13,50 $ aral\u0131\u011f\u0131 \u2192 Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>AL<\/strong> tavsiyesi<br \/> \u015eirketin 2025 i\u00e7in 665-685 milyon $ gelir rehberli\u011fi istikrar\u0131 i\u015faret ederken, maliyet kontrol \u00f6nlemleri marjlar\u0131 iyile\u015ftirmelidir<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 14,00-16,00 $<br \/> <a href=\"https:\/\/www.moomoo.com\/stock\/AVNS-US\/forecast\/\">Moomoo<\/a> analistleri ortalama 12 ayl\u0131k hedefleri yakla\u015f\u0131k 14,00 $ olarak \u00f6ng\u00f6rmekte, daha iyimser tahminler ise 17,34 $ seviyesine kadar \u00e7\u0131kmaktad\u0131r<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 18,00-22,00 $<br \/> D\u00f6n\u00fc\u015f\u00fcm stratejisinin ve pazar geni\u015flemesinin ba\u015far\u0131l\u0131 uygulanmas\u0131 varsay\u0131m\u0131yla<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 25,00 $+ potansiyel<br \/> Sa\u011fl\u0131k harcamalar\u0131ndaki uzun vadeli demografik trendler s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmeyi desteklemektedir<\/li>\n<\/ul>\n<p>Yat\u0131r\u0131m tezi, Avanos&#8217;un d\u00f6n\u00fc\u015f\u00fcm stratejisini ba\u015far\u0131yla uygulamas\u0131 ve ya\u015flanan n\u00fcfus trendleri ile artan sa\u011fl\u0131k harcamalar\u0131ndan faydalanmas\u0131na dayanmaktad\u0131r.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve Avanos Medical birka\u00e7 \u00f6nemli husus sunmaktad\u0131r:<\/p>\n<ul>\n<li><strong>Reg\u00fclasyon Riskleri<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fc yo\u011fun \u015fekilde d\u00fczenlenmi\u015ftir, de\u011fi\u015fiklikler \u00fcr\u00fcn onaylar\u0131n\u0131 ve geri \u00f6deme oranlar\u0131n\u0131 etkileyebilir<\/li>\n<li><strong>Mali Zorluklar<\/strong>: \u015eirket, 2025 2. \u00e7eyrekte de\u011fer d\u00fc\u015f\u00fckl\u00fc\u011f\u00fc giderleri nedeniyle 76,8 milyon $ net zarar bildirmi\u015ftir (<a href=\"https:\/\/www.ainvest.com\/news\/avanos-medical-2025-q2-earnings-sharp-net-loss-revenue-growth-2508\/\">AInvest Raporu<\/a>)<\/li>\n<li><strong>Rekabet Bask\u0131s\u0131<\/strong>: T\u0131bbi cihaz end\u00fcstrisinde rekabet s\u00fcrekli artmaktad\u0131r<\/li>\n<li><strong>Uygulama Riski<\/strong>: D\u00f6n\u00fc\u015f\u00fcm stratejileri her zaman beklenen sonu\u00e7lar\u0131 vermeyebilir<\/li>\n<\/ul>\n<p>Ancak bu riskler, \u015firketin g\u00fc\u00e7l\u00fc piyasa konumlar\u0131 ve \u00f6zel t\u0131bbi \u00e7\u00f6z\u00fcmlerine artan talep ile dengelenmelidir.<\/p>\n<h2>\ud83d\udfe2 Olumlu \u0130\u015faretler: Yat\u0131r\u0131mc\u0131lar\u0131n \u0130yimser Olmas\u0131n\u0131n Nedenleri<\/h2>\n<p>Avanos Medical&#8217;in toparlanmaya haz\u0131r olabilece\u011fini g\u00f6steren birka\u00e7 fakt\u00f6r vard\u0131r:<\/p>\n<ul>\n<li><strong>Birle\u015fik Krall\u0131k Geni\u015fleme Ba\u015far\u0131s\u0131<\/strong>: Temmuz 2025&#8217;te MIC-KEY \u00fcr\u00fcnleri i\u00e7in do\u011frudan operasyonlara ge\u00e7i\u015f (<a href=\"https:\/\/avanos.com\/news\/avanos-expands-direct-operations-for-mic-key-enteral-feeding-products-in-the-uk-starting-july-2025\/\">\u015eirket Duyurusu<\/a>) marjlar\u0131 ve m\u00fc\u015fteri ili\u015fkilerini iyile\u015ftirmelidir<\/li>\n<li><strong>Gelir \u0130stikrar\u0131<\/strong>: 2025 2. \u00e7eyrek sat\u0131\u015flar\u0131 y\u0131ll\u0131k %1,9 art\u0131\u015fla 175 milyon $ olmu\u015ftur<\/li>\n<li><strong>Pazar Liderli\u011fi<\/strong>: Enteral beslenme ve opioid d\u0131\u015f\u0131 a\u011fr\u0131 y\u00f6netiminde g\u00fc\u00e7l\u00fc konumlar<\/li>\n<li><strong>D\u00f6n\u00fc\u015f\u00fcm \u0130lerlemesi<\/strong>: Maliyet y\u00f6netimi ve organizasyonel yeniden yap\u0131land\u0131rma erken sonu\u00e7lar g\u00f6stermektedir<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2>\n<p>Mevcut analizlere dayanarak, yeni yat\u0131r\u0131mc\u0131lar i\u00e7in mant\u0131kl\u0131 olan \u015funlard\u0131r:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3&#8217;\u00fcnden fazlas\u0131n\u0131 temsil etmeyen bir pozisyonla ba\u015flay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Pozisyonunuzu tek seferde b\u00fcy\u00fck al\u0131m yapmak yerine kademeli olarak olu\u015fturmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Daha iyi giri\u015f noktalar\u0131 i\u00e7in 11,50 $ alt\u0131ndaki f\u0131rsatlar\u0131 izleyin<\/li>\n<li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu yat\u0131r\u0131m sab\u0131r gerektirir\u2014aylar de\u011fil, y\u0131llar baz\u0131nda d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<\/ol>\n<p>Mizahi deneyimli t\u00fcccar \u00f6\u011f\u00fcd\u00fc: &#8220;AVNS ticareti t\u0131bbi iyile\u015fme gibidir\u2014bazen uzun vadeli kazan\u00e7 i\u00e7in k\u0131sa vadeli ac\u0131ya katlanman\u0131z gerekir. Ama do\u011fru e\u011fitim olmadan ameliyat yapmaya kalkmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve makul komisyon oranlar\u0131 sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;AVNS&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Emir detaylar\u0131n\u0131 son kez kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Giri\u015f Engeli<\/strong>: 5 $ minimum depozito ile stratejileri \u00f6nemli finansal taahh\u00fct olmadan test edebilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek bir belge ile 1 dakikal\u0131k KYC s\u00fcreci sayesinde hemen i\u015flem yapmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla y\u00f6ntem esneklik sa\u011flar<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve d\u00fc\u015f\u00fck giri\u015f gereksinimleri, Avanos Medical gibi \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Avanos Medical: Sa\u011fl\u0131kta Yenilik Lideri<\/h2>\n<p>Avanos Medical, k\u00fcresel t\u0131bbi teknoloji alan\u0131nda \u00f6nemli bir oyuncu olarak, iki kritik alanda uzmanla\u015fm\u0131\u015ft\u0131r: <strong>Kronik Bak\u0131m<\/strong> ve <strong>A\u011fr\u0131 Y\u00f6netimi<\/strong>. \u015eirket, hastalar\u0131n hastaneden ev bak\u0131m\u0131na ge\u00e7i\u015fini kolayla\u015ft\u0131ran ve opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azaltan narkotik olmayan a\u011fr\u0131 y\u00f6netimi teknolojileri geli\u015ftirmektedir.<\/p>\n<p>\u015eirketin \u00fcr\u00fcn portf\u00f6y\u00fc \u015funlar\u0131 i\u00e7erir:<\/p>\n<ul>\n<li>Hayati beslenme deste\u011fi sa\u011flayan enteral beslenme sistemleri<\/li>\n<li>A\u011fr\u0131 y\u00f6netimi i\u00e7in radyo frekans ablasyon ekipmanlar\u0131<\/li>\n<li>Hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftiren cerrahi iyile\u015fme \u00e7\u00f6z\u00fcmleri<\/li>\n<li>K\u0131r\u0131lgan yenido\u011fanlar i\u00e7in yenido\u011fan yo\u011fun bak\u0131m \u00fcr\u00fcnleri<\/li>\n<\/ul>\n<p>ABD, Avrupa ve Asya&#8217;da faaliyet g\u00f6steren Avanos, k\u00fcresel bir ayak izine sahip olup, kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lara y\u00f6nelik y\u00fcksek marjl\u0131 \u00f6zel \u00fcr\u00fcnlere odaklanmaktad\u0131r.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Avanos, 29 y\u0131ll\u0131k da\u011f\u0131t\u0131m ortakl\u0131\u011f\u0131n\u0131 sonland\u0131rarak Birle\u015fik Krall\u0131k operasyonlar\u0131n\u0131 do\u011frudan kontrol alt\u0131na alm\u0131\u015ft\u0131r\u2014bu cesur hamle, \u00fcr\u00fcnlerine olan g\u00fcveni ve m\u00fc\u015fteri ili\u015fkilerine ba\u011fl\u0131l\u0131\u011f\u0131 g\u00f6stermektedir. Bu stratejik de\u011fi\u015fim 25 Temmuz 2025&#8217;te ba\u015flam\u0131\u015f ve \u015firketin agresif pazar geni\u015fleme yakla\u015f\u0131m\u0131n\u0131 temsil etmektedir.<\/p>\n"},"faq":[{"question":"Avanos Medical hisseleri nereden al\u0131nabilir?","answer":"Avanos Medical hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Avanos Medical hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131, se\u00e7ti\u011finiz ticaret platformuna ba\u011fl\u0131d\u0131r ancak genellikle tek bir hisse fiyat\u0131 kadar d\u00fc\u015f\u00fck olabilir. Yeni ba\u015flayanlar i\u00e7in portf\u00f6ylerinin %2-3'\u00fc kadar k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flamak \u00f6nerilir."},{"question":"Avanos Medical hisselerinin gelecekteki fiyat beklentileri nelerdir?","answer":"Analist tahminlerine g\u00f6re, 2025 sonunda hisse fiyat\u0131 12,50-13,50 $ aral\u0131\u011f\u0131nda olup, 2030 y\u0131l\u0131na kadar 25 $ ve \u00fczeri potansiyel g\u00f6r\u00fclmektedir."},{"question":"Avanos Medical hisselerine yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, mali zorluklar, artan rekabet ve d\u00f6n\u00fc\u015f\u00fcm stratejilerinin ba\u015far\u0131s\u0131z olmas\u0131 gibi riskler bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Avanos Medical hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar maliyet ortalamas\u0131 yaparak, fiyat uyar\u0131lar\u0131 kurarak ve uzun vadeli d\u00fc\u015f\u00fcnerek yat\u0131r\u0131m yapmak ak\u0131ll\u0131ca olacakt\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Avanos Medical hisseleri nereden al\u0131nabilir?","answer":"Avanos Medical hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Avanos Medical hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131, se\u00e7ti\u011finiz ticaret platformuna ba\u011fl\u0131d\u0131r ancak genellikle tek bir hisse fiyat\u0131 kadar d\u00fc\u015f\u00fck olabilir. Yeni ba\u015flayanlar i\u00e7in portf\u00f6ylerinin %2-3'\u00fc kadar k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flamak \u00f6nerilir."},{"question":"Avanos Medical hisselerinin gelecekteki fiyat beklentileri nelerdir?","answer":"Analist tahminlerine g\u00f6re, 2025 sonunda hisse fiyat\u0131 12,50-13,50 $ aral\u0131\u011f\u0131nda olup, 2030 y\u0131l\u0131na kadar 25 $ ve \u00fczeri potansiyel g\u00f6r\u00fclmektedir."},{"question":"Avanos Medical hisselerine yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, mali zorluklar, artan rekabet ve d\u00f6n\u00fc\u015f\u00fcm stratejilerinin ba\u015far\u0131s\u0131z olmas\u0131 gibi riskler bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Avanos Medical hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar maliyet ortalamas\u0131 yaparak, fiyat uyar\u0131lar\u0131 kurarak ve uzun vadeli d\u00fc\u015f\u00fcnerek yat\u0131r\u0131m yapmak ak\u0131ll\u0131ca olacakt\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T04:52:58+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T04:52:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\",\"name\":\"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"datePublished\":\"2025-09-01T04:52:58+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/","og_locale":"tr_TR","og_type":"article","og_title":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T04:52:58+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T04:52:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/","name":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","datePublished":"2025-09-01T04:52:58+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avanos-medical\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Avanos Medical, Inc. (AVNS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Avanos Medical, Inc. (AVNS) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":365133,"slug":"how-to-buy-avanos-medical","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avanos Medical, Inc. (AVNS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avanos Medical, Inc. (AVNS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avanos-medical\/"},"pt_AA":{"locale":"pt_AA","id":365134,"slug":"how-to-buy-avanos-medical","post_title":"Como comprar a\u00e7\u00f5es da Avanos Medical, Inc. (AVNS) - Investimento em a\u00e7\u00f5es da Avanos Medical, Inc. (AVNS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-avanos-medical\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/365130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=365130"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/365130\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334045"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=365130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=365130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=365130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}